Deep Learning-based Classification and Prediction of Radiation Dermatitis in Head and Neck Patients
NCT ID: NCT05607225
Last Updated: 2022-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2022-07-01
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Deep Learning-based sbORN Diagnostic Model
NCT06463392
The Use of Photobiomodulation in the Management of Radiodermatitis in Head and Neck Cancer Patients
NCT05557825
Study on Adaptive Radiotherapy and Multimodal Information of Cervical Cancer Assisted by Artificial Intelligence
NCT04022018
Biomarkers for Prediction of Tumor Response to Radiotherapy
NCT03744819
Exploration of the Safety and Efficacy of T-DXd Concurrent With Brain Radiotherapy in Patients With Brain Metastases HER2-positive/HER2-low Advanced Breast Cancer
NCT07117864
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Grading evaluation Each image was individually graded by three experienced radiotherapy experts according to the RD criteria of RTOG
3. Data analysis Construct a dermatitis grading model basing on deep learning. Evaluate the performance of model using accuracy, precision, recall, F1-measure, dice value.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Histologically or cytologically confirmed head and neck carcinoma confirmed by pathology.
* Receive radical radiotherapy including neck area
* Informed consent.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
YE ZHANG
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ye Zhang, MD
Role: PRINCIPAL_INVESTIGATOR
Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
Li Ma, MD
Role: PRINCIPAL_INVESTIGATOR
Shenzhen Cancer Hospital, Chinese Academy of Medical Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shenzhen Cancer Hospital, Chinese Academy of Medical Sciences
Shenzhen, Guangdong, China
Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Li Ma, MD
Role: primary
Ye Zhang, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JS2022-62
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.